• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMO PUERTO RICO MFG. INC. SENSAR IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMO PUERTO RICO MFG. INC. SENSAR IOL; INTRAOCULAR LENS Back to Search Results
Model Number AR40E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Conjunctivitis (1784); Red Eye(s) (2038); Excessive Tear Production (2235)
Event Date 09/20/2021
Event Type  Injury  
Manufacturer Narrative
Unknown/ not provided.Implant date: unknown, information not provided.Explant date: not applicable, as lens was not explanted.City: unknown/not provided.State, province, or territory: unknown/not provided.Post office or zip code: unknown/not provided.Telephone number: (b)(6).The device is not returning for evaluation as it remains implanted; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
It was reported that patient had intraocular lens (iol) implant in the right eye.Two weeks later, the patient returned due to redness and lacrimation (tearing) in the right eye.Examination showed mild conjunctival congestion in the right eye, weakly positive ciliary tenderness, flocculent exudates in front of the anterior chamber intraocular lens, and sluggish light reflex.Medication was prescribed.Atropine eye gel eye drops three times a day; subconjunctival injection of dexamethasone injection 2.5 mg once; tobramycin dexamethasone eye drops three times a day; tobramycin dexamethasone eye ointment once every night.No further information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENSAR IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
AMO PUERTO RICO MFG. INC.
road 402 north, anasco ind. pk
anasco PR 00610
Manufacturer Contact
somyata nagpal
31 technology drive
irvine, CA 92618
7142478552
MDR Report Key14018360
MDR Text Key293843287
Report Number3012236936-2022-00878
Device Sequence Number1
Product Code HQL
UDI-Device Identifier05050474502154
UDI-Public(01)05050474502154(17)240930
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P980040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAR40E
Device Catalogue NumberAR40E00225
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/30/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-